|
|
||||||||
Institute of Membrane and Systems Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom
Submitted 6 July 2007; accepted in final form 20 September 2007
|
|
ABSTRACT |
|---|
|
|
|
INTRODUCTION |
|---|
|
Cardiovascular responses are influenced by microinjection of mu, delta, and kappa opioid agonists into the NTS, and the delta agonist additionally increases respiratory rate (Hassen et al. 1983
). Gastrointestinal function is also influenced differentially; because microinjection of the mu-opioid agonist [D-Ala2, N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) into the NTS in freely moving rats increased food intake, the delta and kappa agonists were ineffective in motivating this behavior (Kotz et al. 1997
). Such diverse effects may be due to activation of differentially localized pre- or postsynaptic opioid receptors in specific sites within the NTS because there is some degree of topographical organization in the NTS (Altschuler et al. 1991
; Ciriello 1983
; Finley and Katz 1992
; Hayakawa et al. 2001
; Housley et al. 1987
; Leslie et al. 1982
; Zhang et al. 2000
). However, this issue has not been fully addressed at the cellular level.
Previous electrophysiological studies in the NTS have shown that
50% of neurons were hyperpolarized by DAMGO, but there were no postsynaptic effects of delta or kappa opioid receptor agonists, although these drugs were only tested on a low number of neurons (Rhim et al. 1993
). Furthermore this study did not define the location of neurons that were responsive to mu-opioid receptor (MOR) activation. There are also discrepancies in the exact role of presynaptic opioid receptors in modulating synaptic transmission onto NTS neurons. In early studies, excitatory postsynaptic potentials (EPSPs) in most NTS neurons were reduced by DAMGO (Rhim et al. 1993
); however, studies determining the effects of DAMGO on evoked calcium currents observed decreases in either 50% (Rhim and Miller 1994
) or 75% (Endoh 2006
) of neurons tested. In another study, DAMGO reduced solitary tract evoked excitatory postsynaptic currents (EPSCs) in all pro-opiomelanocortin (POMC)-expressing NTS neurons (Appleyard et al. 2005
). Rhim et al. (1993)
also reported that all solitary tract evoked EPSPs were reduced by the kappa agonist U69593
[GenBank]
and delta agonist [D-Pen2,5]-enkephalin (DPDPE); however, in a subsequent paper, the evoked calcium current was decreased by U69593
[GenBank]
in only 3 of 15 cells tested, whereas DPDPE was totally without effect (Rhim and Miller 1994
). These discrepancies in functional studies are mirrored in anatomical studies because the exact extent and location of opioid receptors in the NTS is an area of dispute (Aicher et al. 2000
; Cheng et al. 1996
; Nomura et al. 1996
). Interestingly, the delta opioid receptor (DOR) is often mainly contained within the cytoplasm, away from the plasma membrane (Arvidsson et al. 1995
) and DOR trafficking to the surface must be induced by acute exposure to forskolin or bradykinin before responses are observed (Browning et al. 2004
; Patwardhan et al. 2005
).
Given that previous studies provide an incomplete picture of opioid receptor mediated responses in the NTS, the aim of this study was to further our understanding of the exact role of opioids within the NTS. Because previous discrepancies in results may be due to different recording sites, we mapped the regions of the NTS where activation of mu, kappa, and delta opioid receptor agonists elicited pre- and postsynaptic responses. We demonstrate subdivision specific responses to MOR activation with this electrophysiological data being reinforced by anatomical data at the EM level. Furthermore, we show that kappa agonists can indeed hyperpolarize a small fraction of NTS neurons. This diversity of responses may underlie the differential modulation of autonomic reflexes observed after opioid receptor activation within the NTS.
|
|
METHODS |
|---|
|
Male Wistar rats aged 14–21 days were humanely killed by terminally anesthetizing with sodium pentobarbitone (120 mg/kg, ip) and transcardially perfusing with ice-cold sucrose aCSF, composition (in mM); sucrose (217), NaHCO3 (26), KCl (3), MgSO4 (2), NaH2PO4 (2.5), CaCl 2 (1) and glucose (10). The brain was removed, the brain stem isolated and the dura removed. Coronal slices of 300 µm were cut using a Vibroslice (Campden Instruments) and placed in a holding chamber containing aCSF, composition (in mM); NaCl (124), NaHCO3 (26), KCl (3), MgSO4 (2), NaH2PO4 (2.5), CaCl 2 (1) and glucose (10), to equilibrate in 95% O2, 5% CO2 for
1 h prior to recording. Slices were then transferred to a submerged recording chamber and continually perfused at room temperature via a gravity fed system, with oxygenated aCSF at a rate of 3–6 ml per minute. Patch electrodes (5-6M
) were filled with intracellular solution, composition (in mM); K-Gluconate (110), EGTA (11), MgCl2 (2), CaCl2 (0.1), HEPES (10), Na2ATP(2), and NaGTP (0.3). Neurobiotin (0.5%, Vector Laboratories) and Lucifer yellow (dipotassium salt, 1–2%, Sigma) were included in the intracellular solution and passively diffused into the neuron while recording.
Whole cell patch clamp recordings were made in current clamp mode from visually identified neurons of the NTS using an Axopatch 1D (Axon Instruments) and an upright microscope (Eclipse E600FN; Nikon, Melville, NY; or BX50WI; Olympus Optical, Tokyo). Neurons were held at –60 mV and were characterized by injection of rectangular hyperpolarizing current pulses of –50 to –10 pA (1s duration), changes in voltage were measured and input resistance calculated. These rectangular pulses of 1s duration were of sufficient length for a steady state change in membrane voltage to be observed. Rectangular depolarizing current pulses of +10 to +200 pA were then applied to examine firing properties of the neuron (see (Deuchars et al. 2001b). Following electrophysiological characterization of the neuron, responses to bath applied drugs were determined. Neurons were held at –60 mV (not corrected for liquid junction potentials) to test the effects of the opioid agonists and hyperpolarizing current pulses of –10 to –40 pA injected to monitor changes in input resistance, represented by a change in the size of the voltage response to the injected current. To confirm that changes in input resistance were due to action of the agonist, during the response to the agonist neurons were repolarized back to resting membrane potential to observe changes in input resistance. Antagonists were applied for
5–10 mins prior to application of the agonist.
To investigate presynaptic actions of drugs, a bipolar stimulating electrode (voltage 1–20 V, duration 100 µs, frequency 0.1–0.2 Hz,) was positioned in the solitary tract to evoke postsynaptic potentials in NTS neurons using an isolated stimulator (model DS2A, Digitimer, Hertfordshire, UK).
Drugs used were [D-Ala2, N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO; 0.1–1 µM, Sigma), [D-Pen2,5]-Enkephalin (DPDPE; 1–4 µM, Sigma), U69593
[GenBank]
(10–20 µM), D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP; 1 µM, Sigma), nor-Binaltorphimine dihydrochloride (nor-BNI; 200 nM), tetrodotoxin (TTX citrate; 1 µM, Tocris), D-AP5 (50 µM) and NBQX disodium salt (10–30 µM). All stock solutions were made using distilled water, excluding U69593
[GenBank]
which was made up in 50% ethanol and were stored at –20°C until required. All compounds were then diluted in aCSF and applied into the superfusate at concentrations shown previously to be effective (Browning et al. 2002
; Margolis et al. 2003
; Milligan et al. 2004
; Rhim et al. 1993
).
Neuron location
During visualized patch-clamp recordings neurons were identified as belonging to a particular subdivision of the NTS using a combination of previous references which describe the morphology and orientation of neurons and the rat brain atlas stereotaxic co-ordinates (Kalia and Sullivan 1982
; Paxinos and Watson 1998
; Kalia et al. 1984
). Neurons in the commissural subdivision are typically scattered and are small and oval with their axes lying parallel to the dorsal edge of the medulla. In the dorsolateral subdivision elliptical neurons form a cluster dorsal to the solitary tract, while medial neurons are closely packed and medium sized. Neurons in the intermediate subdivision form a small cluster lying parallel to the solitary tract and neurons in the ventral NTS are medium sized and multipolar (Kalia and Sullivan 1982
; Kalia et al. 1984
).
Data analysis
Data capture was carried out using either Signal (version 1) and Spike 2 (version 2; Cambridge Electronic Design) or pClamp (version 9, Axon Instruments). The input resistance was calculated for each neuron by measurement of the voltage responses to injected current pulses. Excitatory postsynaptic potential (EPSP) amplitudes were calculated by measuring their peak amplitude from the holding potential and were averaged for
10 consecutive sweeps. Changes in EPSP amplitude as a consequence of drug application were expressed as a mean percentage of the control. Assessment of changes in the paired pulse ratio was also carried out (see (Deuchars et al. 2001a). This was calculated by the ratio of the amplitude of the second EPSP to the first EPSP. The paired pulse ratio during drug application was then compared with the control to note any significant change.
The effects of the drugs were tested statistically using the paired Student's t-test, and differences were considered significant when P < 0.05. A two-sample t-test was used to test for differences in electrophysiological characteristics between groups of neurons and in the size of hyperpolarization for the two concentrations of DAMGO (100 nM and 1 µM), differences were considered significant if P < 0.05. The chi-square test for independence was used to determine whether differences were apparent in the presence of 1-phase or 2-phase afterhyperpolarizations in responsive and unresponsive neurons. Significant differences were evident when P < 0.05.
Histology
Following recording, electrodes were very slowly removed from neurons and the slice was immersed in fixative consisting of 4% paraformaldehyde in 0.1 M phosphate buffer for
18 h. Sections were firstly wet mounted and examined under a fluorescence microscope to identify Lucifer yellow filled cells for subsequent localization. Slices were then washed in PBS and incubated for 24–48 h in extravidin-peroxidase (1:250; Sigma), which attaches to the neurobiotin within the neuron and could be visualized with 3,3'diaminobenzidine (DAB, Sigma) (Deuchars et al. 2001b). Sections were dehydrated andmounted in DPX for viewing under the light microscope. This allowed confirmation of their location and enabled more detailed analysis of the basic morphology and size of the recorded neuron.
Immunohistochemistry
Male Wistar rats 150–250 g (n = 7) and 18 days old (n = 3) were anesthetized by intraperitoneal injection of sodium pentobarbitone (60 mg/kg) and transcardially perfused with paraformaldehyde (4%, in 0.1M Phosphate buffer) containing either 0.05% or 0.1% glutaraldehyde if the tissue was required for electron microscopy (n = 2). The brains were removed and placed in the same fixative for 12 h at 4–8°C. Following postfixation, brains were washed in phosphate buffered saline (PBS) and 30–50 µm coronal slices cut on a vibrating microtome (Leica, Milton Keynes, UK) and collected into wells containing PBS.
Sections required for electron microscopy were permeabilized in 50% ethanol for 30 min at room temperature, washed in PBS then incubated in a H2O2 solution for 30 min to block endogenous peroxidase activity. Sections for light microscopy were not treated with 50% ethanol for permeabilization, but had 0.1% TritonX100 added to the primary antibody solution. Tissue processing for light and electron microscope viewing has been described in detail previously (Deuchars et al. 2001a). Briefly, sections were incubated in polyclonal antiserum corresponding to residues 1359–1403 of the carboxy-terminus of the rat mu-opioid receptor (Neuromics, Minneapolis, USA), 1:2000 in PBS. This was localized with secondary biotinylated donkey anti-rabbit (1:200), prior to detection with extra-avidin peroxidase (1:1500) and visualization with DAB. Sections required for light microscopy were dehydrated in increasing concentrations of ethanol and mounted in DPX. Sections for electron microscopy were postfixed in 0.5% osmium tetra oxide and dehydrated in graded ethanol concentrations, 50%, 70%, 90% and 100%. Sections were immersed in Durcupan ACM resin for 12–18 h, mounted on slides, cover-slipped then placed in the oven at 60°C for 48 h to polymerize the resin. Slices were viewed at the light and electron microscope level.
Antigen retrieval methods
As we wanted to visualize MOR immunoreactive cells within the NTS, we used antigen retrieval methods to try to enhance the staining. Prior to incubation in the primary antibody, sections were incubated in 0.1% sodium borohydride for 10 min, washed for 3 x 10 min in PBS then incubated in the primary antibody solution. For the second antigen retrieval method, instead of incubation in sodium borohydride, sections were treated with 10 mM sodium citrate at 80°C for 30 min.
Image capture and electron microscopy
Slides were examined at the light microscope level using a Nikon E600 microscope and images captured using Acquis Image Capture System (Synoptics, Cambridge, UK). These images were adjusted as required using the Corel graphics package version 12. Drawings were constructed using a drawing tube at x40 magnification and were from three representative slices. Areas of sections containing the appropriate staining to examine at the electron microscope level were further processed as previously described (Deuchars et al. 2001a). Electron microscopy was conducted on tissue from two rats, with two separate 80 µm sections from each rat being used for collection of ultrathin (79 nm) sections. Ultrathin sections were collected 6–10 per grid and the identity of labeled structures noted on random sampling of the dlNTS. At least three ultrathin sections were examined per grid. To eliminate the possibility of double counting of labeled structures on separate grids, every third grid was examined.
|
|
RESULTS |
|---|
|
Whole cell patch clamp recordings were obtained from visualized neurons within the NTS. Recordings were performed in current clamp mode so that the firing characteristics of neurons could be assessed. At a holding potential of –60 mV, perfusion of DAMGO (100 nM) evoked a membrane hyperpolarization of 7.4 ± 0.5 mV (Fig. 1A), accompanied by a significant decrease in the input resistance from 1.5 ± 0.09 to 1.1 ± 0.07 G
(P < 0.0005) in 28% of neurons (50/178) in the NTS. At 1 µM DAMGO the amplitude of the hyperpolarizing response was also 7.4 ± 0.5 mV (n = 5, not shown) and was accompanied by a significant decrease in input resistance from 1.3 ± 0.22 G
to 0.8 ± 0.14 G
(P < 0.05, n = 5). The magnitude of hyperpolarization induced by DAMGO at 1 µM was not significantly different from that elicited by 100 nM DAMGO (P > 0.99) suggesting that 100 nM DAMGO evokes near maximal responses. The effect of DAMGO was reversible on washout and repeated doses of DAMGO had similar effects, showing that there was no desensitization in response on repeated application. The first application of DAMGO induced a hyperpolarization of 4.7 ± 0.4 mV with the second application inducing a hyperpolarization of 4.6 ± 0.9 mV (n = 5, not shown). There were no significant differences in the magnitude of hyperpolarization (P > 0.88). The likelihood of the neuron to respond to the postsynaptic actions of DAMGO depended on its location within the NTS (Fig. 1). Hyperpolarizing responses were observed only in the medial (43% of neurons (34/80), Fig. 1A1), dorsomedial (21% of neurons (6/29), Fig. 1A2) and dorsolateral (53% of neurons (10/19), Fig. 1A3) subdivisions. Neurons in the ventral (n = 10, Fig. 1C1), intermediate (n = 16, Fig. 1C2), commissural (n = 12, Fig. 1C3), dorsal (n = 5) and lateral (n = 7) NTS were unresponsive. Neurons unresponsive to 100 nM DAMGO were subsequently shown to be unresponsive to 1 µM DAMGO (n = 14) to further strengthen the separation of responsive and unresponsive neurons. This lack of effect in specific regions was mirrored in our immunohistochemical data which described low densities of immunopositive neurons in regions where no postsynaptic responses were observed (see following text).
|
|
) with application of CTOP (1.8 ± 0.46 G
) or CTOP and DAMGO (1.8 ± 0.47 G
).
|
To determine whether there was any regional specificity in the presynaptic responses to DAMGO, twin-pulse stimuli were applied to the tractus solitarius at 100–400 ms intervals to evoke pairs of EPSPs. If a significant change in the paired pulse ratio occurred then this would be consistent with a presynaptic site of action. DAMGO reduced the peak amplitude of pairs of evoked EPSPs (n = 39); EPSP 1 was reduced to 47.7 ± 2.8% of control and EPSP 2 to 61.8 ± 3.4% of control (Fig. 4). This decrease in amplitude was accompanied by a significant increase in the paired pulse ratio from 0.71 ± 0.03 to 0.94 ± 0.05 (P < 0.0005, Fig. 4D1). These presynaptic effects were observed in all neurons tested, regardless of their location in the NTS and their postsynaptic response to DAMGO (Fig. 4). At this holding potential (-70 mV), these EPSPs were mediated by action at non-NMDA receptors since NBQX (10–30 µM), but not AP-5 (50 µM), abolished these EPSPs (n = 5, Fig. 4B2).
|
The decrease in EPSP peak amplitude and increase in the paired pulse ratio suggests that DAMGO could exert its presynaptic actions through a reduction in neurotransmitter release.
The mu-opioid receptor location correlates with electrophysiological observations
NTS neurons which were responsive and unresponsive to DAMGO were recovered subsequent to electrophysiological recordings. Responsive neurons were present only in the medial, dorsomedial and dorsolateral subdivisions of the NTS (Fig. 1B).
Studies to date have not undertaken a full analysis of the localization of the MOR in different subdivisions of the NTS. Therefore to determine the postsynaptic location of MORs in these subdivisions, immunoreactivity for this receptor was examined in the NTS. Antigen retrieval methods improved the visibility of labeled neurons. Tissue from rats aged 18 day and adult rats was examined and the distribution of MOR-immunoreactivity in the NTS was comparable. This was to be expected since previous studies have also shown similar levels of DAMGO binding in the NTS at these two ages (Xia and Haddad 1991
). Drawings were constructed from three representative slices in the older rats (Fig. 5). At the level primarily used for electrophysiological recordings (Fig. 5A2) MOR immunoreactive neurons were observed in the medial, dorsomedial and dorsolateral subdivisions of the NTS. Since previous immunohistochemical studies have not examined the subcellular localization of the MOR in the dorsal NTS, the dorsolateral NTS was examined at the electron microscope level. Electron microscopy confirmed that the MOR is located at both presynaptic (Fig. 6 F and G) and postsynaptic (Fig. 6H) sites in this region and that MOR immunoreactivity could also be seen presynaptically and postsynaptically at the same synapse (Fig. 6C-E). To quantify this further, 104 MOR immunoreactive structures were identified in the dlNTS. 62 (60%) of these labeled structures were terminals onto unlabeled dendritic elements, 18 (17%) were labeled terminals onto labeled dendrites, 16 (15%) were labeled axons en passage and 8 (8%) were synaptic connections where the postsynaptic structure but not the presynaptic terminal was labeled.
|
|
(Zhu and Pan 2004
) and (Santos et al. 2004
) found that specific populations of neurons within the central nucleus of the amygdala and substantia gelatinosa respectively responded to applications of DAMGO. These neurons displayed different firing patterns, action potential characteristics and input resistance. In contrast, (Rhim et al. 1993
) found no differences in the general properties for neurons within the NTS that were responsive to postsynaptic actions of DAMGO and those that were unresponsive.
To compare the electrophysiological and morphological characteristics of neurons responsive and unresponsive to postsynaptic actions of DAMGO, we took samples of cells from each group in the medial, dorsomedial and dorsolateral subdivisions (Table 1). In the dorsolateral subdivision there were significant differences between the afterhyperpolarization (AHP) amplitude (P < 0.05) and duration (P < 0.05) in responsive and unresponsive neurons (Fig. 7B). The AHP amplitude was 25.1 ± 3.1mV compared with 16.8 ± 2.0 mV and the duration was 65.4 ± 8.4 ms compared with 38.2 ± 5.9 ms in responsive (n = 7) and unresponsive (n = 7) neurons respectively. In neurons of dorsomedial subdivision there was a significant difference (P < 0.05) in AHP duration (37.5 ± 8.3 ms in unresponsive neurons (n = 5) compared with 63.8 ± 7.8 ms in responsive neurons) but no significant difference in AHP amplitude (P > 0.1, Fig. 7C). Action potential amplitude, duration, half-width and cell input resistance were not significantly different in responsive and unresponsive neurons in the dorsolateral and dorsomedial subdivisions (P > 0.1, Fig. 7). In cells within the medial subdivision of the NTS, a two-sample t-test revealed no significant differences between action potential duration, amplitude or half-width and no significant difference between AHP duration and amplitude (P > 0.1, n = 10, Fig. 7A). There was also no significant difference in input resistance (P > 0.5). The chi-square test was used to determine if any differences existed in the occurrence of 1-phase or 2-phase AHPs in neurons responsive or unresponsive to DAMGO. In the dorsolateral subdivision there was a significant difference from the expected (P < 0.05), responsive neurons were more likely to have 1-phase AHPs and unresponsive neurons were more likely to have 2-phase AHPs. In the dorsomedial and medial subdivisions there was no significant difference (P > 0.5). Morphological analysis of responsive and nonresponsive neurons of the medial NTS revealed no significant differences in soma size (P > 0.5) and no consistent differences in soma orientation (Table 2, see Fig. 2 for representative filled neurons).
|
|
|
The delta agonist DPDPE had no postsynaptic effects on neurons in all subdivisions of the NTS (n = 34, not shown), of these 3/22 neurons tested exhibited a postsynaptic response to DAMGO (not shown). The amplitude and paired pulse ratio of pairs of evoked EPSPs (n = 7, not shown) were also unaffected by application of 1–4 µM DPDPE [EPSP1; 103.7 ± 4.5% (P > 0.1) of control values, EPSP 2; 92.2 ± 5.3% (P > 0.1) of control, PPR 0.7 ± 0.1 to 0.6 ± 0.1 (P > 0.1]. Four of these neurons were tested and found to be responsive to presynaptic actions of DAMGO (not shown). Since activation of the MOR may increase DOR receptor trafficking to the membrane surface (see (Cahill et al. 2001
) and discussion), 12 neurons were exposed to DAMGO for 3–5 min prior to application of DPDPE. Following this preexposure to DAMGO, neurons were still unresponsive to the postsynaptic actions of DPDPE. (Patwardhan et al. 2005
) have also demonstrated that preincubation of rat trigeminal ganglia with bradykinin for 15 min results in rapid trafficking of the DOR to the plasma membrane and functional competence of these receptors. In the present study preincubation of slices in 20 µM bradykinin for 15–30 min prior to DPDPE application did not result in an inhibitory response to DPDPE (2 µM, n = 9), even though responses to DAMGO were still observed (not shown).
The kappa opioid agonist U69593 has presynaptic and postsynaptic effects on neurons of the NTS
The kappa opioid receptor (KOR) agonist U69593
[GenBank]
hyperpolarized 6/79 neurons in the NTS (Fig. 8A). The magnitude of this hyperpolarization was 9.7 ± 1.5 mV (10–20 µM). Neurons unresponsive to 20 µM also did not respond to 40 µM U69593.
[GenBank]
A decrease in input resistance from 1.3 ± 0.17 to 0.9 ± 0.15 G
was also observed. Responsive neurons were located in the medial (3/27), dorsomedial (1/11), dorsolateral (1/10) and intermediate (1/9) subdivisions. Twenty two neurons in other subdivisions (commissural, ventral, dorsal and lateral) were unresponsive to U69593.
[GenBank]
Of neurons hyperpolarized by DAMGO and subsequently tested for a response to U69593
[GenBank]
, 3/10 were also hyperpolarized by U69593.
[GenBank]
Thus U69593
[GenBank]
failed to induce a response in seven neurons which were hyperpolarized by DAMGO. In addition, one neuron was not affected by DAMGO but was hyperpolarized by U69593
[GenBank]
therefore it is unlikely that U69593
[GenBank]
was acting nonselectively at MORs.
|
|
|
DISCUSSION |
|---|
|
Location of the mu opioid receptor within the NTS
We found that neurons hyperpolarized by DAMGO were restricted to the medial, dorsomedial, and dorsolateral NTS, which was confirmed after recovery of these neurons. This study extends the work from previous laboratories where the locations of neurons hyperpolarized by DAMGO were not determined, even though only a proportion of NTS neurons were affected (Rhim et al. 1993
). In our study, the distribution of MOR-mediated responses and the location of MOR-immunoreactive cell bodies correlate within the NTS. At the electron microscope level we demonstrated MOR immunoreactivity at pre- and postsynaptic sites in the dorsolateral NTS. Moreover, postsynaptic densities were apposed to presynaptic densities that were both MOR immunoreactive. Such a strong influence from these receptors was confirmed by electrophysiological recordings where we observed both pre- and postsynaptic effects of DAMGO on a proportion of dorsolateral NTS neurons. Our results in the dorsolateral NTS differ from previous studies on the cellular location of the MOR in the medial NTS (Aicher et al. 2000
; Cheng et al. 1996
; Glass and Pickel 2002
; Nomura et al. 1996
) where the majority of MOR labeling was presynaptic. However, because we observed pre- and postsynaptic responses in the same neuron in medial, dorsolateral, and dorsomedial NTS, this, coupled with our electron microscopic data, suggests that neurons expressing postsynaptic MORs are always also influenced by presynaptic MORs.
Neurons responding to activation of postsynaptic MORs display different characteristics
Our studies showed differences in the properties of some of the NTS neurons responding to activation of postsynaptic MORs. In the dorsolateral NTS, neurons with postsynaptic responses to DAMGO had significantly larger AHP amplitudes and durations than unresponsive neurons, whereas responsive neurons in the dorsomedial subdivision had a significantly longer AHP. Such neuron-specific responses to DAMGO have been previously reported by Zhu and Pan (2004)
and Santos et al. (2004)
in the central nucleus of the amygdala and substantia gelatinosa, respectively. This observation that neurons in the NTS with specific electrophysiological characteristics respond to MOR activation may aid in the functional identification of neurons in future studies. There were no morphological characteristics exhibited exclusively by neurons with postsynaptic MORs. This may be expected because the morphology of neurons in different NTS regions tends to be heterogeneous and does not necessarily reflect function (Deuchars et al. 2000
; Paton et al. 2000
, 2001
). A similar lack of morphological differences in neurons exhibiting postsynaptic responses to DAMGO has also been reported in the central nucleus of the amygdala (Zhu and Pan 2004
).
Possible functional significances of region specificity of MOR responses
Our electrophysiological and anatomical data report postsynaptic MORs only in the medial, dorsomedial, and dorsolateral regions of the NTS. Many studies support a role for these subdivisions in cardiorespiratory control. Tracing studies report a specific band of afferent inputs from aortic baroreceptor (Ciriello 1983
), carotid body (Finley and Katz 1992
), lungs (Donoghue et al. 1982
), and chemoreceptor (Donoghue et al. 1984
) afferents lying across the medial, dorsomedial, and dorsolateral regions of the NTS, the regions where we observed our postsynaptic effects with MOR activation. Baroreceptive neurons were located in the dorsomedial and medial NTS (Deuchars et al. 2000
), whereas chemoreceptive neurons were more common in the dorsolateral and medial NTS (Paton et al. 2001
). Phenylphrine-induced hypertension resulted in a band of fos-labeled neurons in medial, dorsomedial, and dorsolateral subdivisions (Chan and Sawchenko 1998
; Mayne et al. 1998
), as did formalin injection into the lung complementing the distribution of pulmonary afferent fibers (Xie et al. 1998
). Indeed this region is often referred to as the cardiorespiratory region (e.g., see Paton et al. 1993
), although it must be noted that there is a moderate degree of afferent input to these regions from superior laryngeal (Altschuler et al. 1989
) and stomach wall (Leslie et al. 1982
), and thus there may be some degree of heterogeneity with respect to function of neurons. However, our report shows that only a proportion of neurons in the medial, dorsolateral, and dorsomedial regions are influenced by postsynaptic MORs, which could still fit therefore with a specific role of these neurons in cardiorespiratory control. This suggestion is further supported by our observation that responsive neurons exhibited different firing characteristics.
DOR agonist DPDPE has no effect on neurons of the NTS
In the NTS, discrepancies exist in reports detailing the extent and distribution of the DOR. Reports of low levels of DOR mRNA (Mansour et al. 1993
, 1994
) or DOR binding (Quirion et al. 1983
) contrasts with others describing very strong DOR labeling (Arvidsson et al. 1995
; Goodman et al. 1980
; Kivell et al. 2004
). Any DORs present are likely to be D1 opioid receptors because the NTS was devoid of deltorphin binding sites (Mennicken et al. 2003
). We observed no pre- or postsynaptic effects on application of DPDPE to neurons in any of the NTS subdivisions, similar to previous observations (Rhim et al. 1993
). This lack of effect may be due to DOR location because in the NTS, DOR was mainly contained within the cytoplasm, away from the plasma membrane (Arvidsson et al. 1995
). Chronic application of morphine can increase DOR density at the cell surface, an effect blocked by the MOR antagonist CTOP and absent in MOR knockout mice, demonstrating that the MOR is required for DOR targeting to the cell membrane (Cahill et al. 2001
; Morinville et al. 2003
). Opioid receptor trafficking to the membrane can be induced after 5 min of forskolin exposure (Browning et al. 2004
), whereas redistribution of DORs from the cytoplasm to the cell membrane by bradykinin exposure took
1.5 min (Patwardhan et al. 2005
). In our study, pretreatment with either DAMGO or bradykinin (receptors known to be localized in the NTS) (Caligiorne et al. 1996
; Chen et al. 2000
; Privitera et al. 2003
) failed to induce DOR postsynaptic responses. This suggests that such a mechanism was not responsible for the lack of effects observed here and may support those studies that show little or no DORs in the NTS.
Kappa agonist U69593 has pre- and postsynaptic effects in the NTS
A previous study in the NTS had reported no postsynaptic effects with the KOR agonist U69593
[GenBank]
at 10 µM (Rhim et al. 1993
) although only seven neurons were tested with the drug. This is pertinent because in this study, a small proportion of neurons were hyperpolarized by U69593.
[GenBank]
In fact, U69593
[GenBank]
hyperpolarized just 7.5% of neurons in the NTS, compared with the 28% that were hyperpolarized by DAMGO. The fact that this small proportion of neurons was affected however may be significant since the average hyperpolarization observed was over 9 mV, twice the amplitude of that elicited with DAMGO. Only a percentage of neurons was responsive to both DAMGO and U69593
[GenBank]
and this, along with the high degree of selectivity of U69593
[GenBank]
at KORs (Emmerson et al. 1994
; Lahti et al. 1985
) and the observation that presynaptic effects were blocked by a KOR antagonist, indicates that the effect is due to a selective action at KORs. This subpopulation of neurons express KORs postsynaptically that may exert a powerful but selective inhibition of NTS neurons. In the caudal NTS dense KOR1 immunoreactivity has been demonstrated in axons (Mansour et al. 1996
), indicating a predominantly presynaptic site of action which fits with our findings of few postsynaptic receptor mediated responses. In keeping with this, we have also shown that U69593
[GenBank]
reduced the amplitude and increased the paired pulse ratio of EPSPs in
50% of NTS neurons suggesting a more widespread distribution of presynaptic KORs.
In summary, the electrophysiological and morphological data from these studies provides a comprehensive report of the role of the three opioid receptors in the control of NTS neuronal activity. These data highlight a selective role for opioid receptors in the control of NTS excitability.
|
|
GRANTS |
|---|
|
|
|
ACKNOWLEDGMENTS |
|---|
|
|
|
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: S. A. Deuchars, Institute of Membrane and Systems Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK (E-mail S.A.Deuchars{at}leeds.ac.uk)
|
|
REFERENCES |
|---|
|
Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker JM. Endogenous opioids: biology and function. Annu Rev Neurosci 7: 223–255, 1984.[CrossRef][Web of Science][Medline]
Altschuler SM, Bao XM, Bieger D, Hopkins DA, Miselis RR. Viscerotopic representation of the upper alimentary tract in the rat: sensory ganglia and nuclei of the solitary and spinal trigeminal tracts. J Comp Neurol 283: 248–268, 1989.[CrossRef][Web of Science][Medline]
Altschuler SM, Ferenci DA, Lynn RB, Miselis RR. Representation of the cecum in the lateral dorsal motor nucleus of the vagus nerve and commissural subnucleus of the nucleus tractus solitarii in rat. J Comp Neurol 304: 261–274, 1991.[CrossRef][Web of Science][Medline]
Appleyard SM, Bailey TW, Doyle MW, Jin YH, Smart JL, Low MJ, Andresen MC. Proopiomelanocortin neurons in nucleus tractus solitarius are activated by visceral afferents: regulation by cholecystokinin and opioids. J Neurosci 25: 3578–3585, 2005.
Arvidsson U, Dado RJ, Riedl M, Lee JH, Law PY, Loh HH, Elde R, Wessendorf MW. delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci 15: 1215–1235, 1995.[Abstract]
Browning KN, Kalyuzhny AE, Travagli RA. Opioid peptides inhibit excitatory but not inhibitory synaptic transmission in the rat dorsal motor nucleus of the vagus. J Neurosci 22: 2998–3004, 2002.
Browning KN, Kalyuzhny AE, Travagli RA. Mu-opioid receptor trafficking on inhibitory synapses in the rat brain stem. J Neurosci 24: 7344–7352, 2004.
Burks TF, Fox DA, Hirning LD, Shook JE, Porreca F. Regulation of gastrointestinal function by multiple opioid receptors. Life Sci 43: 2177–2181, 1988.[CrossRef][Web of Science][Medline]
Cahill CM, Morinville A, Lee MC, Vincent JP, Collier B, Beaudet A. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci 21: 7598–7607, 2001.
Caligiorne SM, Santos RA, Campagnole-Santos MJ. Cardiovascular effects produced by bradykinin microinjection into the nucleus tractus solitarii of anesthetized rats. Brain Res 720: 183–190, 1996.[CrossRef][Web of Science][Medline]
Chan RK, Sawchenko PE. Organization and transmitter specificity of medullary neurons activated by sustained hypertension: implications for understanding baroreceptor reflex circuitry. J Neurosci 18: 371–387, 1998.
Chen EY, Emerich DF, Bartus RT, Kordower JH. B2 bradykinin receptor immunoreactivity in rat brain. J Comp Neurol 427: 1–18, 2000.[CrossRef][Medline]
Cheng PY, Liu-Chen LY, Chen C, Pickel VM. Immunolabeling of Mu opioid receptors in the rat nucleus of the solitary tract: extrasynaptic plasmalemmal localization and association with Leu5-enkephalin. J Comp Neurol 371: 522–536, 1996.[CrossRef][Web of Science][Medline]
Ciriello J. Brain stem projections of aortic baroreceptor afferent fibers in the rat. Neurosci Lett 36: 37–42, 1983.[CrossRef][Web of Science][Medline]
Deuchars J, Li YW, Kasparov S, Paton JF. Morphological and electrophysiological properties of neurons in the dorsal vagal complex of the rat activated by arterial baroreceptors. J Comp Neurol 417: 233–249, 2000.[CrossRef][Web of Science][Medline]
Deuchars SA, Brooke RE, Deuchars J. Adenosine A1 receptors reduce release from excitatory but not inhibitory synaptic inputs onto lateral horn neurons. J Neurosci 21: 6308–6320, 2001.
Deuchars SA, Brooke RE, Frater B, Deuchars J. Properties of interneurones in the intermediolateral cell column of the rat spinal cord: role of the potassium channel subunit Kv3.1. Neuroscience 106: 433–446, 2001.[CrossRef][Web of Science][Medline]
Donoghue S, Felder RB, Jordan D, Spyer KM. The central projections of carotid baroreceptors and chemoreceptors in the cat: a neurophysiological study. J Physiol 347: 397–409, 1984.
Donoghue S, Garcia M, Jordan D, Spyer KM. The brain-stem projections of pulmonary stretch afferent neurones in cats and rabbits. J Physiol 322: 353–363, 1982.
Emmerson PJ, Liu MR, Woods JH, Medzihradsky F. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther 271: 1630–1637, 1994.
Endoh T. Pharmacological characterization of inhibitory effects of postsynaptic opioid and cannabinoid receptors on calcium currents in neonatal rat nucleus tractus solitarius. Br J Pharmacol 147: 391–401, 2006.[CrossRef][Web of Science][Medline]
Finley JC, Katz DM. The central organization of carotid body afferent projections to the brain stem of the rat. Brain Res 572: 108–116, 1992.[CrossRef][Web of Science][Medline]
Glass MJ, Pickel VM. Alpha(2A)-adrenergic receptors are present in mu-opioid receptor containing neurons in rat medial nucleus tractus solitarius. Synapse 43: 208–218, 2002.[CrossRef][Web of Science][Medline]
Goodman RR, Snyder SH, Kuhar MJ, Young WS III. Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography. Proc Natl Acad Sci USA 77: 6239–6243, 1980.
Hassen AH, Feuerstein G, Faden AI. Differential cardiovascular effects mediated by mu and kappa opiate receptors in hindbrain nuclei. Peptides 4: 621–625, 1983.[CrossRef][Web of Science][Medline]
Hayakawa T, Takanaga A, Maeda S, Seki M, Yajima Y. Subnuclear distribution of afferents from the oral, pharyngeal and laryngeal regions in the nucleus tractus solitarii of the rat: a study using transganglionic transport of cholera toxin. Neurosci Res 39: 221–232, 2001.[CrossRef][Web of Science][Medline]
Housley GD, Martin-Body RL, Dawson NJ, Sinclair JD. Brain stem projections of the glossopharyngeal nerve and its carotid sinus branch in the rat. Neuroscience 22: 237–250, 1987.[CrossRef][Web of Science][Medline]
Kalia M, Fuxe K, Hokfelt T, Johansson O, Lang R, Ganten D, Cuello C, Terenius L. Distribution of neuropeptide immunoreactive nerve terminals within the subnuclei of the nucleus of the tractus solitarius of the rat. J Comp Neurol 222: 409–444, 1984.[CrossRef][Web of Science][Medline]
Kalia M, Sullivan JM. Brain stem projections of sensory and motor components of the vagus nerve in the rat. J Comp Neurol 211: 248–265, 1982.[CrossRef][Web of Science][Medline]
Kivell BM, Day DJ, McDonald FJ, Miller JH. Developmental expression of mu and delta opioid receptors in the rat brain stem: evidence for a postnatal switch in micro isoform expression. Brain Res Dev Brain Res 148: 185–196, 2004.[CrossRef][Medline]
Kotz CM, Billington CJ, Levine AS. Opioids in the nucleus of the solitary tract are involved in feeding in the rat. Am J Physiol Regulatory Integrative Comp Physiol 272: R1028–R1032, 1997.
Lahti RA, Mickelson MM, McCall JM, Von Voigtlander PF. [3H]U-69593 a highly selective ligand for the opioid kappa receptor. Eur J Pharmacol 109: 281–284, 1985.[CrossRef][Web of Science][Medline]
Leslie RA, Gwyn DG, Hopkins DA. The central distribution of the cervical vagus nerve and gastric afferent and efferent projections in the rat. Brain Res Bull 8: 37–43, 1982.[CrossRef][Web of Science][Medline]
Mansour A, Burke S, Pavlic RJ, Akil H, Watson SJ. Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary. Neuroscience 71: 671–690, 1996.[CrossRef][Web of Science][Medline]
Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350: 412–438, 1994.[CrossRef][Web of Science][Medline]
Mansour A, Thompson RC, Akil H, Watson SJ. Delta opioid receptor mRNA distribution in the brain: comparison to delta receptor binding and proenkephalin mRNA. J Chem Neuroanat 6: 351–362, 1993.[CrossRef][Web of Science][Medline]
Margolis EB, Hjelmstad GO, Bonci A, Fields HL. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci 23: 9981–9986, 2003.
Mayne RG, Armstrong WE, Crowley WR, Bealer SL. Cytoarchitectonic analysis of Fos-immunoreactivity in brain stem neurons following visceral stimuli in conscious rats. J Neuroendocrinol 10: 839–847, 1998.[CrossRef][Web of Science][Medline]
Mennicken F, Zhang J, Hoffert C, Ahmad S, Beaudet A, O'Donnell D. Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia. J Comp Neurol 465: 349–360, 2003.[CrossRef][Web of Science][Medline]
Milligan CJ, Buckley NJ, Garret M, Deuchars J, Deuchars SA. Evidence for inhibition mediated by coassembly of GABAA and GABAC receptor subunits in native central neurons. J Neurosci 24: 7241–7250, 2004.
Morinville A, Cahill CM, Esdaile MJ, Aibak H, Collier B, Kieffer BL, Beaudet A. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. J Neurosci 23: 4888–4898, 2003.
Nomura S, Ding YQ, Kaneko T, Li JL, Mizuno N. Localization of mu-opioid receptor-like immunoreactivity in the central components of the vagus nerve: a light and electron microscope study in the rat. Neuroscience 73: 277–286, 1996.[CrossRef][Web of Science][Medline]
Paton JF, Deuchars J, Li YW, Kasparov S. Properties of solitary tract neurones responding to peripheral arterial chemoreceptors. Neuroscience 105: 231–248, 2001.[CrossRef][Web of Science][Medline]
Paton JF, Foster WR, Schwaber JS. Characteristic firing behavior of cell types in the cardiorespiratory region of the nucleus tractus solitarii of the rat. Brain Res 604: 112–125, 1993.[CrossRef][Web of Science][Medline]
Paton JF, Li YW, Deuchars J, Kasparov S. Properties of solitary tract neurons receiving inputs from the sub-diaphragmatic vagus nerve. Neuroscience 95: 141–153, 2000.[CrossRef][Web of Science][Medline]
Patwardhan AM, Berg KA, Akopain AN, Jeske NA, Gamper N, Clarke WP, Hargreaves KM. Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J Neurosci 25: 8825–8832, 2005.
Paxinos G, Watson C. The Rat Brain Atlas in Stereotaxic Coordinates. San Diego, CA: Academic Press, 1998.
Privitera PJ, Beckstead RM, Yates P, Walgren R. Autoradiographic localization of [125I-Tyr0]bradykinin binding sites in brains of Wistar-Kyoto and spontaneously hypertensive rats. Cell Mol Neurobiol 23: 805–815, 2003.[CrossRef][Web of Science][Medline]
Quirion R, Zajac JM, Morgat JL, Roques BP. Autoradiographic distribution of mu and delta opiate receptors in rat brain using highly selective ligands. Life Sci 33, Suppl 1: 227–230, 1983.[CrossRef][Web of Science][Medline]
Rhim H, Glaum SR, Miller RJ. Selective opioid agonists modulate afferent transmission in the rat nucleus tractus solitarius. J Pharmacol Exp Ther 264: 795–800, 1993.
Rhim H, Miller RJ. Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat. J Neurosci 14: 7608–7615, 1994.[Abstract]
Santos SF, Melnick IV, Safronov BV. Selective postsynaptic inhibition of tonic-firing neurons in substantia gelatinosa by mu-opioid agonist. Anesthesiology 101: 1177–1183, 2004.[CrossRef][Web of Science][Medline]
Shook JE, Kazmierski W, Wire WS, Lemcke PK, Hruby VJ, Burks TF. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors. J Pharmacol Exp Ther 246: 1018–1025, 1988.
Shook JE, Watkins WD, Camporesi EM. Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. Am Rev Respir Dis 142: 895–909, 1990.[Web of Science][Medline]
Spyer KM. The central nervous organisation of reflex circulatory control. In: Central Regulation of Autonomic Functions, edited by Loewy AD and Spyer KM. Oxford, UK: Oxford Univ. Press, 1990.
Waldhoer M, Bartlett SE, Whistler JL. Opioid receptors. Annu Rev Biochem 73: 953–990, 2004.[CrossRef][Web of Science][Medline]
Xia Y, Haddad GG. Ontogeny and distribution of opioid receptors in the rat brainstem. Brain Res 549: 181–193, 1991.[CrossRef][Web of Science][Medline]
Xie Q, Miki T, Sato K, Itoh M, Takeuchi Y. Evaluation of pulmonary afferent fibers in the nucleus tractus solitarius: a horseradish peroxidase and c-fos like immunohistochemical study in the rat. J Auton Nerv Syst 74: 120–125, 1998.[CrossRef][Web of Science][Medline]
Zhang X, Renehan WE, Fogel R. Vagal innervation of the rat duodenum. J Auton Nerv Syst 79: 8–18, 2000.[CrossRef][Web of Science][Medline]
Zhu W, Pan ZZ. Synaptic properties and postsynaptic opioid effects in rat central amygdala neurons. Neuroscience 127: 871–879, 2004.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
A. G. Stucke, E. J. Zuperku, A. Sanchez, M. Tonkovic-Capin, V. Tonkovic-Capin, S. Mustapic, and E. A. Stuth Opioid Receptors on Bulbospinal Respiratory Neurons Are Not Activated During Neuronal Depression by Clinically Relevant Opioid Concentrations J Neurophysiol, November 1, 2008; 100(5): 2878 - 2888. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Andresen and J. H. Peters Comparison of baroreceptive to other afferent synaptic transmission to the medial solitary tract nucleus Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2032 - H2042. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. S. Pattinson Opioids and the control of respiration Br. J. Anaesth., June 1, 2008; 100(6): 747 - 758. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |